Back to Trades
Hite Christopher
EVP & ChairmanPartneringCIK 0001814238
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 9
- Companies
- 3
- Active
- 2025–2026
Hite Christopher, EVP & Chairman, Partnering, accounts for 9 disclosed filings worth $28.0M, spread across 3 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $27.4M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Sep 24 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Sell | $5.9M |
| Aug 19 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Sell | $6.0M |
| Aug 7 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Grant | $0 |
| Jul 2 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Sell | $7.3M |
| Jun 25 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Sell | $8.2M |
| Apr 20 | KLRA Kailera Therapeutics, Inc. | Hite Christopher | Insider | Award | $612.8K |
| Apr 16 | KLRA Kailera Therapeutics, Inc. | Hite Christopher | Insider | Other | $0 |
| Mar 9 | VERA Vera Therapeutics, Inc. | Hite Christopher | Insider | Other | $0 |
| Aug 8 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Grant | $0 |
9 filings